The Swissmedic Marketing Authorisation for Global Health Products (MAGHP) Procedure – Progress update and lessons learned
February 23, 2021 – The SDC held a virtual event in collaboration with Swissmedic, the Swiss Agency for Therapeutic Products, and an expert panel from national medical authorities (Tanzania, Ghana) and the World Health Organisation (WHO).
The main objectives were to present the Swissmedic Marketing Authorisation for Global Health Products (MAGHP) and its added value in terms of capacity strengthening and access to medical products, particularly in low-income countries. Guest speakers presented lessons learned from first experiences, in particular in Tanzania and Ghana, and discussed the main benefits and challenges of MAGHP's procedure, as well as possible ways to move forward.
Speakers: Jörg Schläpfer & Lodovico Paganini (TMDA) experience in the MAGHP procedure, Felchism Apolnary, Nathaniel Nkrumah, Dr. Petra Doerr
Moderator: Dr. Alexandre Schulze, co-head of Global Programme Health, SDC
Please find the recording here